Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Cesano

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
The Journal of Clinical Investigation|September 1, 1994
Reversal of acute myelogenous leukemia in humanized SCID mice using a novel adoptive transfer approachA Cesano, S Visonneau, L Cioé, et al.
International Journal of Oncology|May 3, 2011
Potent tumoricidal effects of a human cytotoxic T-cell line (TALL-104) against prostate cancerT Umiel, M Campbell, S Cho, et al.
Oncogene|May 1, 1992
The severe combined immunodeficient (SCID) mouse as a model for human myeloid leukemiasA Cesano, J A Hoxie, B Lange, et al.
Blood|May 15, 1993
Establishment of a karyotypically normal cytotoxic leukemic T-cell line from a T-ALL sample engrafted in SCID miceA Cesano, R O'Connor, P C Nowell, et al.
Anticancer Research|March 1, 1997
Conjugated linoleic acid suppresses the growth of human breast adenocarcinoma cells in SCID miceS Visonneau, A Cesano, S A Tepper, et al.
International Journal of Immunopharmacology|October 1, 1992
Normal development of lymphokine activated killing (LAK) in peripheral blood lymphocytes from hyperprolactinemic patientsL Matera, E Ciccarelli, G Muccioli, et al.
Annals of the New York Academy of Sciences|April 15, 1992
Cerebrospinal fluid and plasma concentrations of POMC-related peptides in multiple sclerosisL Pinessi, I Rainero, T de Gennaro, et al.
Journal of Clinical & Laboratory Immunology|October 1, 1988
Effect of cortisol on the native and in vitro induced non-MHC restricted cytotoxicity of large granular lymphocytesL Matera, E Cardoso, F Veglia, et al.
Cancer Research|July 1, 1996
Phase I clinical trial with a human major histocompatibility complex nonrestricted cytotoxic T-cell line (TALL-104) in dogs with advanced tumorsA Cesano, S Visonneau, K A Jeglum, et al.
International Journal of Oncology|January 26, 1999
Effects of development of host immunity on the biodistribution of xenogeneic MHC non-restricted cytotoxic T cells: implications for adoptive cell therapy of cancerA Cesano, J A Wortman, M Pourdehnad, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
The Journal of Clinical Investigation|September 1, 1994
Reversal of acute myelogenous leukemia in humanized SCID mice using a novel adoptive transfer approachA Cesano, S Visonneau, L Cioé, et al.
International Journal of Oncology|May 3, 2011
Potent tumoricidal effects of a human cytotoxic T-cell line (TALL-104) against prostate cancerT Umiel, M Campbell, S Cho, et al.
Oncogene|May 1, 1992
The severe combined immunodeficient (SCID) mouse as a model for human myeloid leukemiasA Cesano, J A Hoxie, B Lange, et al.
Blood|May 15, 1993
Establishment of a karyotypically normal cytotoxic leukemic T-cell line from a T-ALL sample engrafted in SCID miceA Cesano, R O'Connor, P C Nowell, et al.
Anticancer Research|March 1, 1997
Conjugated linoleic acid suppresses the growth of human breast adenocarcinoma cells in SCID miceS Visonneau, A Cesano, S A Tepper, et al.
International Journal of Immunopharmacology|October 1, 1992
Normal development of lymphokine activated killing (LAK) in peripheral blood lymphocytes from hyperprolactinemic patientsL Matera, E Ciccarelli, G Muccioli, et al.
Annals of the New York Academy of Sciences|April 15, 1992
Cerebrospinal fluid and plasma concentrations of POMC-related peptides in multiple sclerosisL Pinessi, I Rainero, T de Gennaro, et al.
Journal of Clinical & Laboratory Immunology|October 1, 1988
Effect of cortisol on the native and in vitro induced non-MHC restricted cytotoxicity of large granular lymphocytesL Matera, E Cardoso, F Veglia, et al.
Cancer Research|July 1, 1996
Phase I clinical trial with a human major histocompatibility complex nonrestricted cytotoxic T-cell line (TALL-104) in dogs with advanced tumorsA Cesano, S Visonneau, K A Jeglum, et al.
International Journal of Oncology|January 26, 1999
Effects of development of host immunity on the biodistribution of xenogeneic MHC non-restricted cytotoxic T cells: implications for adoptive cell therapy of cancerA Cesano, J A Wortman, M Pourdehnad, et al.
Pageof 6